Cargando…

Impact of changes in controlled drugs legislation on benzodiazepine receptor agonist prescribing in Ireland: a repeated cross-sectional study

PURPOSE: To examine the impact of new controlled drugs legislation introduced in May 2017 on benzodiazepine receptor agonist (BZRA) prescribing in Ireland. METHODS: A repeated cross-sectional analysis was conducted using publically available monthly pharmacy claims data from the General Medical Serv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cadogan, Cathal A., Bradley, Colin P., Bennett, Kathleen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Pharmacoepidemiology and Prescription
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128812/ https://www.ncbi.nlm.nih.gov/pubmed/33410969 http://dx.doi.org/10.1007/s00228-020-03063-z

Ejemplares similares

Pharmacoepidemiology resources in Ireland—an introduction to pharmacy claims data
por: Sinnott, Sarah-Jo, et al.
Publicado: (2017)

Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and z-drugs consumption in nine European countries
por: Clay, Emilie, et al.
Publicado: (2012)

Prevalence of potentially inappropriate prescribing and prescribing omissions in older Irish adults: findings from The Irish LongituDinal Study on Ageing study (TILDA)
por: Galvin, Rose, et al.
Publicado: (2014)

Hospitalisations related to benzodiazepine, Z-drug, and opioid treatment in Italy: a claim on the risks associated with inappropriate use
por: Mattioli, Irene, et al.
Publicado: (2022)

Potentially inappropriate prescribing in two populations with differing socio-economic profiles: a cross-sectional database study using the PROMPT criteria
por: Cooper, Janine A., et al.
Publicado: (2016)

Longitudinal prevalence of potentially inappropriate medicines and potential prescribing omissions in a cohort of community-dwelling older people
por: Moriarty, Frank, et al.
Publicado: (2015)

Discrepancies between prescribed and defined daily doses: a matter of patients or drug classes?
por: Grimmsmann, Thomas, et al.
Publicado: (2011)

Potentially inappropriate prescribing and adverse drug reactions in the elderly: a population-based study
por: Hedna, Khedidja, et al.
Publicado: (2015)

Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus
por: Morin, Lucas, et al.
Publicado: (2018)

Hospital electronic prescribing system implementation impact on discharge information communication and prescribing errors: a before and after study
por: Mills, Pamela Ruth, et al.
Publicado: (2017)

Number of drugs in the medication list as an indicator of prescribing quality: a validation study of polypharmacy indicators in older hip fracture patients
por: Belfrage, Björn, et al.
Publicado: (2015)

How useful are prescribing indicators based on the DU90% method to distinguish the quality of prescribing between pharmacotherapy audit meetings with different levels of functioning?
por: Teichert, Martina, et al.
Publicado: (2007)

Harmonization of summaries of product characteristics (SmPCs) of drugs with the same active ingredients: an evaluation of SmPCs of the most frequently prescribed active substances
por: Gahr, Maximilian, et al.
Publicado: (2021)

Defining antimicrobial prescribing quality indicators: what is a new prescription?
por: Boesten, Jos, et al.
Publicado: (2010)

Prevalence of suboptimal drug treatment in patients with and without multidose drug dispensing—a cross-sectional study
por: Belfrage, Björn, et al.
Publicado: (2014)

Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson’s disease
por: Arbouw, Maurits E. L., et al.
Publicado: (2009)

Dopamine agonists and ischemic complications in Parkinson’s disease: a nested case–control study
por: Arbouw, Maurits E. L., et al.
Publicado: (2011)

Trends and variations in the prescribing of secondary preventative cardiovascular therapies for non-ST elevation myocardial infarction (NSTEMI) in Malaysia
por: Venkatason, Padmaa, et al.
Publicado: (2018)

Clinical relevance of potentially inappropriate medications and potential prescribing omissions according to explicit criteria—a validation study
por: Parodi López, Naldy, et al.
Publicado: (2022)

Ability to detect potentially inappropriate prescribing in older patients: comparative analysis between PIM-Check and STOPP/STARTv2
por: Farhat, Akram, et al.
Publicado: (2021)

Prescribing medications of questionable benefit prior to death: a retrospective study on older nursing home residents with and without dementia in Germany
por: Rausch, Christian, et al.
Publicado: (2020)

Potentially inappropriate prescribing in older hospitalized Dutch patients according to the STOPP/START criteria v2: a longitudinal study
por: Damoiseaux-Volman, Birgit A., et al.
Publicado: (2020)

EurOP(2)E – the European Open Platform for Prescribing Education, a consensus study among clinical pharmacology and therapeutics teachers
por: Bakkum, Michiel J., et al.
Publicado: (2021)

Vitamin D deficiency as adverse drug reaction? A cross-sectional study in Dutch geriatric outpatients
por: van Orten-Luiten, A. C. B., et al.
Publicado: (2016)

Developing confidence in basic prescribing skills during medical school: a longitudinal questionnaire study investigating the effects of a modified clinical pharmacology course
por: Eriksson, Anna L., et al.
Publicado: (2018)

Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson’s disease: a multiple treatment comparison meta-analysis
por: Binde, Caroline D., et al.
Publicado: (2020)

Psychotropic drug use among older people with major neurocognitive disorder: a cross-sectional study based on Swedish national registries
por: Kindstedt, Jonas, et al.
Publicado: (2021)

Drug use in pregnant women—a pilot study of the coherence between reported use of drugs and presence of drugs in plasma
por: Wolgast, Emelie, et al.
Publicado: (2017)

Clinically relevant drug–drug interactions among elderly people with dementia
por: Sönnerstam, Eva, et al.
Publicado: (2018)

A 1-year cross-sectional analysis of non-interventional post-marketing study protocols submitted to the German Federal Institute for Drugs and Medical Devices (BfArM)
por: von Jeinsen, Beatrice K. J. G., et al.
Publicado: (2013)

Sex differences in spontaneous reports on adverse drug events for common antihypertensive drugs
por: Rydberg, Diana M, et al.
Publicado: (2018)

Use of rivaroxaban in Germany: a database drug utilization study of a drug started in hospital
por: Jobski, Kathrin, et al.
Publicado: (2014)

Correct use of non-indexed eGFR for drug dosing and renal drug-related problems at hospital admission
por: Seiberth, Sarah, et al.
Publicado: (2020)

Predictors of orphan drug approval in the European Union
por: Heemstra, Harald E., et al.
Publicado: (2008)

Non-persistence to antihypertensive drug therapy in Lithuania
por: Treciokiene, Indre, et al.
Publicado: (2022)

Factors associated with time consumption when answering drug-related queries to Scandinavian drug information centres: a multi-centre study
por: Reppe, Linda Amundstuen, et al.
Publicado: (2014)

Are multidose drug dispensing systems initiated for the appropriate patients?
por: Mertens, Bram J., et al.
Publicado: (2018)

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
por: van Hunsel, Florence, et al.
Publicado: (2010)

Systematic review of safety in paediatric drug trials published in 2007
por: Nor Aripin, Khairun Nain Bin, et al.
Publicado: (2011)

In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children
por: ter Horst, P. G. J., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_elnbc2qhudc90q02dqu28q0qji